Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: In vivo assessment of cell to plasma ratio of miR-92a

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Ohyashiki, Junko H ^a   Umezu, Tomohiro ^a   Kobayashi, Chiaki ^a   Hamamura, Ryoko S ^a   Tanaka, Masami ^a   Kuroda, Masahiko ^a   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MUS; MUS MUSCULUS;

EID: 78650326322     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-347     Document Type: Article

References (27)

1. MicroRNAs: new regulators of immune cell development and function. D Baltimore MP Boldin RM O'Connell DS Rao KD Taganov, Nat Immunol 2008 9 839 845 10.1038/ni.f.209 18645592
2. MicroRNAs: genomics, biogenesis, mechanism, and function. DP Bartel, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438
3. MicroRNAs: small RNAs with a big role in gene regulation. L He GJ Hannon, Nat Rev Genet 2004 5 522 531 10.1038/nrg1379 15211354
4. Oncomirs - microRNAs with a role in cancer. A Esquela-Kerscher FJ Slack, Nat Rev Cancer 2006 6 259 269 10.1038/nrc1840 16557279
5. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. CH Lawrie S Gal HM Dunlop B Pushkaran AP Liggins K Pulford AH Banham F Pezzella J Boultwood JS Wainscoat CS Hatton AL Harris, Br J Haematol 2008 141 672 675 10.1111/j.1365-2141.2008.07077. x 18318758
6. Circulating microRNAs as stable blood-based markers for cancer detection. PS Mitchell RK Parkin EM Kroh BR Fritz SK Wyman EL Pogosova-Agadjanyan A Peterson J Noteboom KC O'Briant A Allen DW Lin N Urban CW Drescher BS Knudsen DL Stirewalt R Gentleman RL Vessella PS Nelson DB Martin M Tewari, P Natl Acad Sci USA 2008 105 10513 10518 10.1073/pnas.0804549105
7. Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation. T Kaddar WW Chien Y Bertrand MP Pages JP Rouault G Salles M Ffrench JP Magaud, Leuk Res 2009 33 1217 1223 10.1016/j.leukres.2008.12.015 19195700
8. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. M Tanaka K Oikawa M Takanashi M Kudo J Ohyashiki K Ohyashiki M Kuroda, PLoS One 2009 4 5532 10.1371/journal.pone.0005532 19440243
9. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Y Hayashita H Osada Y Tatematsu H Yamada K Yanagisawa S Tomida Y Yatabe K Kawahara Y Sekido T Takahashi, Cancer Res 2005 65 9628 9632 10.1158/0008-5472.CAN-05-2352 16266980
10. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. H Matsubara T Takeuchi E Nishikawa K Yanagisawa Y Hayashita H Ebi H Yamada M Suzuki M Nagino Y Nimura H Osada T Takahashi, Oncogene 2007 26 6099 6105 10.1038/sj.onc.1210425 17384677
11. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. S Takakura N Mitsutake M Nakashima H Namba VA Saenko TI Rogounovitch Y Nakazawa T Hayashi A Ohtsuru S Yamashita, Cancer Sci 2008 99 1147 1154 10.1111/j.1349-7006.2008.00800.x 18429962
12. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. E Connolly M Melegari P Landgraf T Tchaikovskaya BC Tennant BL Slagle LE Rogler M Zavolan T Tuschl CE Rogler, Am J Pathol 2008 173 856 864 10.2353/ajpath.2008.080096 18688024
13. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. M Inomata H Tagawa YM Guo Y Kameoka N Takahashi K Sawada, Blood 2009 113 396 402 10.1182/blood-2008-07-163907 18941111
14. The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1. JH Ohyashiki C Kobayashi R Hamamura S Okabe T Tauchi K Ohyashiki, Cancer Sci 2009 100 970 977 10.1111/j.1349-7006.2009.01131.x 19298223
15. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Z Li J Lu M Sun S Mi H Zhang RT Luo P Chen Y Wang M Yan Z Qian MB Neilly J Jin Y Zhang SK Bohlander DE Zhang RA Larson MM Le Beau MJ Thirman TR Golub JD Rowley J Chen, Proc Natl Acad Sci USA 2008 105 15535 15540 10.1073/pnas.0808266105 18832181
16. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. M Jongen-Lavrencic SM Sun MK Dijkstra PJ Valk B Lowenberg, Blood 2008 111 5078 5085 10.1182/blood-2008-01-133355 18337557
17. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. R Garzon S Liu M Fabbri Z Liu CE Heaphy E Callegari S Schwind J Pang J Yu N Muthusamy V Havelange S Volinia W Blum LJ Rush D Perrotti M Andreeff CD Bloomfield JC Byrd K Chan LC Wu CM Croce G Marcucci, Blood 2009 113 6411 6418 10.1182/blood-2008-07-170589 19211935
18. miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. A Kotani D Ha J Hsieh PK Rao D Schotte ML den Boer SA Armstrong HF Lodish, Blood 2009 114 4169 4178 10.1182/blood-2008-12-191619 19749093
19. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. H Zhang XQ Luo P Zhang LB Huang YS Zheng J Wu H Zhou LH Qu L Xu YQ Chen, PLoS One 2009 4 7826 10.1371/journal.pone.0007826 19915715
20. MicroRNAs: new players in acute myeloid leukaemia. V Havelange R Garzon CM Croce, Br J Cancer 2009 101 743 748 10.1038/sj.bjc.6605232 19672257
21. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Z Huang D Huang S Ni Z Peng W Sheng X Du, Int J Cancer 2009 121 118 126
22. Role of miRNAs in the progression of malignant melanoma. DW Mueller AK Bosserhoff, Br J Cancer 2009 101 551 556 10.1038/sj.bjc.6605204 19638982
23. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. NJ Park H Zhou D Elashoff BS Henson DA Kastratovic E Abemayor DT Wong, Clin Cancer Res 2009 15 5473 5477 10.1158/1078-0432.CCR-09- 0736 19706812
24. MiPred: classification of real and pseudo microRNA precursors using random forest prediction model with combined features. P Jiang H Wu W Wang W Ma X Sun Z Lu, Nucleic Acids Res 2007 35 339 344 10.1093/nar/gkm368 17553836
25. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. KS Khabar, J Interferon Cytokine Res 2005 25 1 10 10.1089/jir.2005.25.1 15684617
26. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. A Zernecke K Bidzhekov H Noels E Shagdarsuren L Gan B Denecke M Hristov T Koppel MN Jahantigh E Lutgens S Wang EN Olson A Schober C Weber, Sci Signal 2009 2 a81 10.1126/scisignal.2000610 19996457
27. Secretory mechanisms and intercellular transfer of microRNAs in living cells. N Kosaka H Iguchi Y Yoshioka F Takeshita Y Matsuki T Ochiya, J Biol Chem 2010 285 17442 17452 10.1074/jbc.M110.107821 20353945